Philippe Quittet

Dept Hematol Univ Montpellier

关注

立即认领

关注

立即认领

基本信息

浏览量：5

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 62 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Blinatumomab after R-CHOP Bridging Therapy for Patients with Richter Transformation: a Phase 2 Multicentre Trial

Romain Guieze,Loic Ysebaert,Damien Roos-Weil,Luc-Mathieu Fornecker,Emmanuelle Ferrant,Lysiane Molina,Therese Aurran,Aline Clavert,Sophie de Guibert,Anne-Sophie Michallet,Alain Saad,Bernard Drenou,Philippe Quittet,Benedicte Hivert,Kamel Laribi,Julie Gay,Anne Quinquenel,Julien Broseus,Valerie Rouille,David Schwartz,Benoit Magnin,Gregory Lazarian,Lauren Veronese,Marie de Antonio,Camille Laurent,Olivier Tournilhac,Bruno Pereira,Pierre Feugier

Nature Communicationsno. 1 (2024)

引用0浏览0WOSNATURE引用

Bosutinib for Patients with Previously Treated Chronic Myeloid Leukemia: Results from the French Observational Boseval Study

Philippe Rousselot,Jean-Christophe Ianotto,Philippe Quittet,Maya Hacini,Gabrielle Roth-Guepin,Mathieu Meunier,Frederic Maloisel,Valerie Coiteux,Gabriel Etienne

BLOOD（2024）

引用0浏览0引用

The Phase 2 LYSA Study of Prednisone, Vinblastine, Doxorubicin, and Bendamustine for Untreated Hodgkin Lymphoma in Older Patients

Herve Ghesquieres,Daphne Krzisch,Emmanuelle Nicolas-Virelizier,Salim Kanoun,Anne Claire Gac,Stephanie Guidez,Mohamed Touati,Kamel Laribi,Franck Morschhauser,Christophe Bonnet,Agathe Waultier-Rascalou,Frederique Orsini-Piocelle,Marc Andre,Marguerite Fournier,Fabienne Morand,Alina Berriolo-Riedinger,Barbara Burroni,Diane Damotte,Alexandra Traverse-Glehen,Philippe Quittet,Olivier Casasnovas

BLOOD（2024）

引用4浏览0WOS引用

18-Months Follow-up of the Trial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting

Franck E. Nicolini,Aude Charbonnier,Martine Escoffre-Barbe,Eric Jourdan,Gabrielle Roth-Guepin,Marc G. Berger,Shanti Ame, Marion Simonet,Hyacinthe A Johnson-Ansah,Viviane Dubruille,Amandine Charbonnier,Philippe Rousselot,Corentin Orvain,Bertrand Joly,Jean-Christophe Ianotto,Emilie Cayssials,Mathieu Meunier,Anne Parry,Valerie Coiteux,Laurence Legros,Hacene Zerazhi,Gabriel Etienne,Philippe Quittet,Ollivier Legrand,Amelie Penot,Lydia Roy,Charlotte Doublet,Stéphane Morisset,Romaine Mayet,Gwenaëlle Garin,Stéphanie Dulucq,Françoise Huguet

Bloodno. Supplement 1 (2024): 478-478

引用0浏览0引用

S210: AN OPEN-LABEL, GLOBAL, PHASE (PH) 1B/2 STUDY ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH PRIMARY OR SECONDARY MYELOFIBROSIS (MF) WHO HAVE A SUBOPTIMAL RESPONSE TO RUX

John Mascarenhas,Tania Jain,Salman Otoukesh,Aaron T. Gerds,Alessandro Lucchesi,Iberia Romina Sosa,Kamel Laribi,Elena Mishchenko,Atanas Radinoff,Giulia Benevolo,Alessandro M. Vannucchi,Francoise Boyer,Philippe Quittet,Markus Radsak,Antoine Machet,Prithviraj Bose, Zhuying Huang,Hope Qamoos,Jesse Mcgreivy,Wayne P. Rothbaum,Srdan Verstovsek,Francesco Passamonti

HemaSphere（2023）

引用2浏览0引用

T Rial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting. Report of the First Therapeutic Sequence

Franck E. Nicolini,Aude Charbonnier,Martine Escoffre-Barbe,Eric Jourdan,Gabrielle Roth-Guepin,Marc G. Berger,Shanti Ame, Marion Simonet,Hyacinthe A. Johnson-Ansah,Viviane Dubruille,Amandine Charbonnier,Philippe Rousselot,Corentin Orvain,Bertrand Joly,Jean-Christophe Ianotto,Emilie Cayssials,Mathieu Meunier,Anne Parry,Valerie Coiteux,Laurence Legros,Hacene Zerazhi,Gabriel Etienne,Philippe Quittet,Ollivier Legrand,Amelie Penot,Lydia Roy,Ludovic Fouillet,Stephane Morisset,Isabelle Tigaud,Romaine Mayet,Gwenaelle Garin, Jerome Guitton,Stephanie Dulucq,Francoise Huguet

BLOOD (2023)

引用1浏览0引用

Tislelizumab, an Anti-PD1 Antibody, in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma in Tirhol Bgb-A317-210: A Prospective Multicenter Lysa Phase 2 Study Conducted in Western Countries

Herve Ghesquieres,Krimo Bouabdallah,Marc Andre,Philippe Quittet,Cecile Borel,Aspasia Stamatoulas Bastard,Michael Gilbertson,Fabien Le Bras,Catherine Thieblemont,Baptiste Delapierre,Mohamed Touati,Pierre Feugier,Julien Lazarovici,Nadine Morineau,Thomas Gastinne,Isabelle Chaillol,Rod Ramchandren,Harsh Shah,Dipenkumar Modi,Heather Allewelt,Pierre Fustier, Jianfeng Xu, Amit Agarwal,Franck Morschhauser,Cedric Rossi

BLOOD（2023）

引用1浏览0引用

Final Results of Brentuximab Vedotin Combined with Ifosfamide-Carboplatin-etoposide in First Refractory/relapsed Hodgkin Lymphoma: a Lymphoma Study Association Phase I/II Study

Aspasia Stamatoullas,Herve Ghesquieres,Pierre Feugier,Marc Andre,Fabien Le Bras,Anne-Claire Gac,Cecile Borel,Thomas Gastinne,Philippe Quittet,Franck Morschhauser,Vincent Ribrag,Stephanie Guidez,Emmanuelle Nicolas-Virelizier,Alina Berriolo-Riedinger,Thierry Vander Borght,Veronique Edeline,Pauline Brice

Leukemia & lymphoma/Leukemia and lymphoma（2022）

引用5浏览0WOS引用

Blinatumomab for Patients with Richter Syndrome: Final Results of the Phase 2 Blinart Trial from the Filo Group

Romain Guieze,Loic Ysebaert,Damien Roos-Weil,Lysiane Molina,Luc Mathieu Fornecker,Therese Aurran,Anne-Sophie Michallet,Emmanuelle Ferrant,Aline Clavert,Alain Saad,Sophiede Guibert,Bernard Drenou,Philippe Quittet,Benedicte Hivert,Kamel Laribi,Julie Gay,Julien Broseus,Valerie Rouille,David Schwartz,Bruno Pereira,Alain Delmer,Pierre Feugier

Blood（2021）

引用10浏览0引用

Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy

Sylvain Lamure,Francois Van Laethem,Delphine De Verbizier,Claire Lozano,Eve Gehlkopf,Jean-Jacques Tudesq,Chris Serrand,Mehdi Benzaoui,Tarik Kanouni,Adeline Quintard,John De Vos,Emmanuelle Tchernonog,Laura Platon,Xavier Ayrignac,Patrice Ceballos,Anne Sirvent, Mickael Francois, Hanane Guedon,Philippe Quittet,Cedric Mongellaz,Aurelie Conte,Charles Herbaux,Caroline Bret,Naomi Taylor,Valerie Dardalhon,Guillaume Cartron

Cancers（2021）

引用22浏览0WOS引用

加载更多

作者统计

#Papers: 62

#Citation: 2000

H-Index: 23

G-Index: 44

Sociability: 6

Diversity: 2

Activity: 5

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn